Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of sprague dawley rat

Anesthesiology

Volumn 115, Issue 4, 2011, Pages 743-753

  Gauthier, Elizabeth A ^a   Guzick, Sarah E ^a   Brummett, Chad M ^a   Baghdoyan, Helen A ^a   Lydic, Ralph ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BUPRENORPHINE; ESZOPICLONE; FENTANYL; ISOFLURANE; MORPHINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; DIALYSIS; ELECTRODE; ELECTROENCEPHALOGRAPHY; ELECTRONEUROGRAPHY; FOREBRAIN; INTRAVENOUS CATHETER; MALE; MICRODIALYSIS; NONHUMAN; PONS RETICULAR FORMATION; PONTINE NUCLEUS; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP; SLEEP WAKING CYCLE; SPRAGUE DAWLEY RAT; SUBSTANTIA INNOMINATA; WAKEFULNESS;

EID: 80053360036     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31822e9f85     Document Type: Article

References (66)

1. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E: Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ 2006; 174:1589-94 (Pubitemid 43829515)
2. Noble M, Tregear SJ, Treadwell JR, Schoelles K: Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage 2008; 35:214-28
3. Cronin A, Keifer JC, Baghdoyan HA, Lydic R: Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist. Br J Anaesth 1995; 74:188-92
4. Dimsdale JE, Norman D, DeJardin D, Wallace MS: The effect of opioids on sleep architecture. J Clin Sleep Med 2007; 3:33-6 (Pubitemid 46761006)
5. Keifer JC, Baghdoyan HA, Lydic R: Sleep disruption and increased apneas after pontine microinjection of morphine. ANESTHESIOLOGY 1992; 77:973-82
6. Shaw IR, Lavigne G, Mayer P, Choinière M: Acute intravenous administration of morphine perturbs sleep architecture in healthy pain-free young adults: A preliminary study. Sleep 2005; 28:677-82 (Pubitemid 40798709)
7. Sittl R, Griessinger N, Likar R: Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebocontrolled trial. Clin Ther 2003; 25:150-68 (Pubitemid 36206743)
8. Baghdoyan HA: Hyperalgesia induced by REM sleep loss: A phenomenon in search of a mechanism. Sleep 2006; 29: 137-9 (Pubitemid 44019964)
9. Haack M, Mullington JM: Sustained sleep restriction reduces emotional and physical well-being. Pain 2005; 119:56-64 (Pubitemid 41752965)
10. Kundermann B, Krieg JC, Schreiber W, Lautenbacher S: The effect of sleep deprivation on pain. Pain Res Manag 2004; 9:25-32 (Pubitemid 38443486)
11. Menefee LA, Cohen MJ, Anderson WR, Doghramji K, Frank ED, Lee H: Sleep disturbance and nonmalignant chronic pain: A comprehensive review of the literature. Pain Med 2000; 1:156-72
12. Naughton F, Ashworth P, Skevington SM: Does sleep quality predict pain-related disability in chronic pain patients? The mediating roles of depression and pain severity. Pain 2007; 127:243-52 (Pubitemid 46073410)
13. Hakki Onen S, Alloui A, Jourdan D, Eschalier A, Dubray C: Effects of rapid eye movement (REM) sleep deprivation on pain sensitivity in the rat. Brain Res 2001; 900:261-7 (Pubitemid 32382120)
14. Roehrs T, Roth T: Sleep and pain: Interaction of two vital functions. Semin Neurol 2005; 25:106-16 (Pubitemid 40471631)
15. Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T: Sleep loss and REM sleep loss are hyperalgesic. Sleep 2006; 29: 145-51 (Pubitemid 44019967)
16. Smith MT, Edwards RR, McCann UD, Haythornthwaite JA: The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 2007; 30:494-505 (Pubitemid 46668707)
17. Rogers NL, Szuba MP, Staab JP, Evans DL, Dinges DF: Neuroimmunologic aspects of sleep and sleep loss. Semin Clin Neuropsychiatry 2001; 6:295-307
18. Clemons M, Regnard C, Appleton T: Alertness, cognition and morphine in patients with advanced cancer. Cancer Treat Rev 1996; 22:451-68 (Pubitemid 27199236)
19. Sjøgren P: Psychomotor and cognitive functioning in cancer patients. Acta Anaesthesiol Scand 1997; 41:159-61 (Pubitemid 27072920)
20. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, McCarley RW: Adenosine: A mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997; 276:1265-8
21. Gan TJ, Habib AS: Adenosine as a non-opioid analgesic in the perioperative setting. Anesth Analg 2007; 105:487-94 (Pubitemid 47196432)
22. Coleman CG, Baghdoyan HA, Lydic R: Dialysis delivery of an adenosine A2A agonist into the pontine reticular formation of C57BL/6J mouse increases pontine acetylcholine release and sleep. J Neurochem 2006; 96:1750-9 (Pubitemid 43351632)
23. Marks GA, Shaffery JP, Speciale SG, Birabil CG: Enhancement of rapid eye movement sleep in the rat by actions at A1 and A2a adenosine receptor subtypes with a differential sensitivity to atropine. Neuroscience 2003; 116:913-20 (Pubitemid 36160583)
24. Van Dort CJ, Baghdoyan HA, Lydic R: Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. J Neurosci 2009; 29:871-81
25. Kalinchuk AV, Urrila AS, Alanko L, Heiskanen S, Wigren HK, Suomela M, Stenberg D, Porkka-Heiskanen T: Local energy depletion in the basal forebrain increases sleep. Eur J Neurosci 2003; 17:863-9 (Pubitemid 36315256)
26. Nelson AM, Battersby AS, Baghdoyan HA, Lydic R: Opioidinduced decreases in rat brain adenosine levels are reversed by inhibiting adenosine deaminase. ANESTHESIOLOGY 2009; 111:1327-33
27. Freye E, Anderson-Hillemacher A, Ritzdorf I, Levy JV: Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients. Pain Pract 2007; 7:123-9 (Pubitemid 46901548)
28. Kress HG: Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain 2009; 13: 219-30
29. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, 6th edition. London, Elsevier, 2007
30. Osman NI, Baghdoyan HA, Lydic R: Morphine inhibits acetylcholine release in rat prefrontal cortex when delivered systemically or by microdialysis to basal forebrain. ANESTHESIOLOGY 2005; 103:779-87 (Pubitemid 41415526)
31. Tanase D, Martin WA, Baghdoyan HA, Lydic R: G protein activation in rat ponto-mesencephalic nuclei is enhanced by combined treatment with a mu opioid and an adenosine A1 receptor agonist. Sleep 2001; 24:52-62 (Pubitemid 32096735)
32. Watson CJ, Lydic R, Baghdoyan HA: Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine. Neuroscience 2007; 144:375-86 (Pubitemid 44841996)
33. Gades NM, Danneman PJ, Wixson SK, Tolley EA: The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contemp Top Lab Anim Sci 2000; 39:8-13
34. Wang W, Baghdoyan HA, Lydic R: Leptin replacement restores supraspinal cholinergic antinociception in leptin-deficient obese mice. J Pain 2009; 10:836-43
35. Watson SL, Watson CJ, Baghdoyan HA, Lydic R: Thermal nociception is decreased by hypocretin-1 and an adenosine A1 receptor agonist microinjected into the pontine reticular formation of Sprague Dawley rat. J Pain 2010; 11:535-44
36. Dirig DM, Salami A, Rathbun ML, Ozaki GT, Yaksh TL: Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods 1997; 76:183-91 (Pubitemid 27428253)
37. Lydic R, Baghdoyan HA: Neurochemical mechanisms mediating opioid-induced REM sleep disruption, Sleep and Pain. Edited by Lavigne G, Sessle BJ, Choinière M, Soja PJ. Seattle, WA, International Association for the Study of Pain (IASP) Press, 2007, pp 99-122
38. Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T: Sustained efficacy of eszopiclone over 6 months of nightly treatment: Results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003; 26:793-9 (Pubitemid 39610622)
39. Lavigne G, Sessle BJ, Choiniére M, Soja PJ, editors: Sleep and Pain. Seattle, WA, International Association for the Study of Pain (IASP) Press, 2007
40. Lavigne GJ: Effect of sleep restriction on pain perception: Towards greater attention! Pain 2010; 148:6-7
41. Watson CJ, Soto-Calderon H, Lydic R, Baghdoyan HA: Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness. Sleep 2008; 31:453-64 (Pubitemid 351694267)
42. Zhu Z, Bowman HR, Baghdoyan HA, Lydic R: Morphine increases acetylcholine release in the trigeminal nuclear complex. Sleep 2008; 31:1629-37
43. Vanini G, Watson CJ, Lydic R, Baghdoyan HA: Gamma-aminobutyric acid-mediated neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia. ANESTHESIOLOGY 2008; 109:978-88
44. Hambrecht-Wiedbusch VS, Gauthier EA, Baghdoyan HA, Lydic R: Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation. Sleep 2010; 33: 909-18
45. Fudala PJ, Jaffe JH, Dax EM, Johnson RE: Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther 1990; 47:525-34 (Pubitemid 20151479)
46. Orman JS, Keating GM: Buprenorphine/naloxone: A review of its use in the treatment of opioid dependence. Drugs 2009; 69:577-607
47. Ponizovsky AM, Margolis A, Heled L, Rosca P, Radomislensky I, Grinshpoon A: Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance. Subst Use Misuse 2010; 45:288-313
48. Yamamoto T, Shono K, Tanabe S: Buprenorphine activates mu and opioid receptor like-1 receptors simultaneously, but the analgesic effect is mainly mediated by mu receptor activation in the rat formalin test. J Pharmacol Exp Ther 2006; 318:206-13
49. Gordon A, Callaghan D, Spink D, Cloutier C, Dzongowski P, O'Mahony W, Sinclair D, Rashiq S, Buckley N, Cohen G, Kim J, Boulanger A, Piraino PS, Eisenhoffer J, Harsanyi Z, Darke AC, Michalko KJ: Buprenorphine transdermal system in adults with chronic low back pain: A randomized, doubleblind, placebo-controlled crossover study, followed by an open-label extension phase. Clin Ther 2010; 32:844-60
50. Karlsson M, Berggren AC: Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study. Clin Ther 2009; 31:503-13
51. Baker FC, Maloney S, Driver HS: A comparison of subjective estimates of sleep with objective polysomnographic data in healthy men and women. J Psychosom Res 1999; 47:335-41
52. Chhangani BS, Roehrs TA, Harris EJ, Hyde M, Drake C, Hudgel DW, Roth T: Pain sensitivity in sleepy pain-free normals. Sleep 2009; 32:1011-7
53. Bonafide CP, Aucutt-Walter N, Divittore N, King T, Bixler EO, Cronin AJ: Remifentanil inhibits rapid eye movement sleep but not the nocturnal melatonin surge in humans. ANESTHESIOLOGY 2008; 108:627-33 (Pubitemid 351440583)
54. Van Dongen HP, Maislin G, Mullington JM, Dinges DF: The cumulative cost of additional wakefulness: Dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003; 26:117-26 (Pubitemid 39610686)
55. Arnedt JT, Conroy DA, Brower KJ: Treatment options for sleep disturbances during alcohol recovery. J Addict Dis 2007; 26:41-54
56. Brower KJ, Perron BE: Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances. Med Hypotheses 2010; 74:928-33
57. Mahfoud Y, Talih F, Streem D, Budur K: Sleep disorders in substance abusers: How common are they? Psychiatry 2009; 6:38-42
58. Steriade M, McCarley RW: Brain Control of Wakefulness and Sleep, 2nd edition. New York, Plenum Press, 2005
59. Friedman L, Bergmann BM, Rechtschaffen A: Effects of sleep deprivation on sleepiness, sleep intensity, and subsequent sleep in the rat. Sleep 1979; 1:369-91 (Pubitemid 9248066)
60. Brunner DP, Dijk DJ, Borbély AA: Repeated partial sleep deprivation progressively changes in EEG during sleep and wakefulness. Sleep 1993; 16:100-13 (Pubitemid 23060475)
61. Tobler I, Borbély AA: Sleep EEG in the rat as a function of prior waking. Electroencephalogr Clin Neurophysiol 1986; 64:74-6 (Pubitemid 16085217)
62. Feinberg I, Floyd TC, March JD: Effects of sleep loss on delta (0.3-3 Hz) EEG and eye movement density: New observations and hypotheses. Electroencephalogr Clin Neurophysiol 1987; 67:217-21 (Pubitemid 17136292)
63. Greenwald MK, Roehrs TA: Mu-opioid self-administration vs passive administration in heroin abusers produces differential EEG activation. Neuropsychopharmacology 2005; 30: 212-21 (Pubitemid 40024416)
64. Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T: Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006; 59:1052-60 (Pubitemid 43849658)
65. Porkka-Heiskanen T, Alanko L, Kalinchuk A, Stenberg D: Adenosine and sleep. Sleep Med Rev 2002; 6:321-32 (Pubitemid 36527690)
66. Rudolph JL, Marcantonio ER: Postoperative delirium: Acute change with long-term implications. Anesth Analg 2011; 112: 1201-11